ArticleJournal for immunotherapy of cancer2019

Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.

Jing Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.